Genomic research is at risk from ‘race science’ activists’ discredited ideas
By Bill Newman and Demetra Georgiou,
The Guardian
| 11. 03. 2024
We were alarmed to read the findings of your investigation into an international network of “race science” activists seeking to influence public debate with discredited ideas on race and eugenics (Revealed: International ‘race science’ network secretly funded by US tech boss, 16 October).
As organisations representing leading researchers and clinicians working in human genetics, we can state unequivocally that race is a fluid social, historical and political construct with no biological or genetic basis. There is convincing evidence that there is more genetic variation within self-identified racial groups than there is between them. It is also widely recognised that the eugenics movement of the late 19th and early 20th centuries was not based on scientific evidence, as set out recently by the Royal College of Physicians in a statement on the history of the UK’s eugenics movement.
We firmly believe that equality, equity, diversity, inclusion and respect for data privacy are central to improving healthcare through research. We recognise that it may not always be possible to prevent malicious actors from hacking datasets and databases and from making...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
By Antonio Regalado, MIT Technology Review | 10.31.2025
A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create genetically edited babies, marking the largest known investment into the taboo technology.
The new company, called Preventive, is...